Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-22

Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer

View source ↗

Summary

Observational study results for Avastin (bevacizumab) in metastatic breast cancer have been posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2016-02-22